Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 21

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 21
---
 of the date of this proxy statement/prospectus (without giving effect to the Business Combination, or the       
 PIPE Investment), FutureTech’s fully diluted share capital would be 16,310,036 FutureTech Common Stock equivalents.                      |
|    | Upon                                                                                                                                     
 completion of the Business Combination, we anticipate that: (1) shares issued to existing holders of Longevity Common Stock (including   
 holders receiving shares issued in connection with the Target Acquisitions) will represent an ownership interest of approximately        
 36.2% of the issued and outstanding Common Stock on a fully diluted basis, (2) shares issued to FutureTech public stockholders will      
 represent an ownership interest of approximately 44.0% of the issued and outstanding FutureTech Common Stock on a fully diluted basis,   
 (3) shares issued to the Sponsor Persons will represent an ownership interest of approximately 14.0% of the issued and outstanding       
 FutureTech Common Stock on a fully diluted basis, (4) shares issued to the Sponsor pursuant to the Sponsor Convertible Promissory        
 Note, assuming the respective exercise of the option to convert amounts owed under the notes into FutureTech Common Stock at the         
 Closing, will represent an ownership interest of 1.3% of the issued and outstanding FutureTech Common Stock on a fully diluted basis,    
 (5) shares issued to the PIPE Investor in the PIPE Investment will represent an ownership interest of approximately 3.6% of the issued   
 and outstanding FutureTech Common Stock on a fully diluted basis, and (6) the representative shares and the shares issued to the         
 underwriters of FutureTech’s initial public offering as a portion of the deferred underwriting fee will represent an ownership           
 interest of approximately 0.9% of the issued and outstanding FutureTech Common Stock on a fully diluted basis. These ownership interest  
 levels are based on Longevity’s capitalization as of January 24, 2025, give effect to the issuance of equity upon exercise               
 of any Warrants and Longevity Options and assumes (i) no additional issuance of Longevity equity (other than shares issued in connection 
 with the Target Acquisitions immediately prior to the Merger), (ii) the Closing occurs on [●], 2025, (iii) 1,000,000 shares              
 of FutureTech Common Stock are issued in connection with the PIPE Investment, and (iv) no public stockholders exercise their redemption  
 rights in connection with the Business Combination.                                                                                      |

The following table illustrates the varying ownership levels in Future